News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million


7/7/2014 6:41:06 AM

Sarepta may be hiring, but others are hiring too! Check it out! (Isn't it tempting?)

A Cambridge pharmaceutical company, which makes a drug that treats muscular dystrophy in young boys, recently announced it is buying the vacant Eisai research lab at 100 Federal St. in a deal worth $25 million.

Sarepta Therapeutic’s purchase of the facility, which was built in 1996 and upgraded in 2006 by Japan-based cancer-research company Eisai, should be finalized by next week.

Last November, Eisai announced layoffs of 72 employees from its Federal Street facility, part of a larger, company-wide layoff.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES